Effective and affordable therapeutics for endocannabinoid deficiencies

 
 

The Endocannabinoid system & the gut

The endocannabinoid system (ECS) is a network of cells and molecules responsible for human homeostasis and is highly concentrated in the gastrointestinal tract. Biotica Bio leverages the human microbiome to target the ECS and treat a wide range of inflammatory and nervous system conditions, beginning with inflammatory bowel disease.

 
 
 
The interactions between gut microbiota and its host involve a complex network of metabolic pathways and biologically active molecules along the gut-brain axis. An imbalance within this relationship leads to diverse pathogenic conditions, including multiple sclerosis, cognitive decline, fibromyalgia, migraine, and addiction. Biotica Bio’s proprietary technology interacts with specific tissues and ameliorates inflammatory waves where they begin.

The interactions between gut microbiota and its host involve a complex network of metabolic pathways and biologically active molecules along the gut-brain axis. An imbalance within this relationship leads to diverse pathogenic conditions, including multiple sclerosis, cognitive decline, fibromyalgia, migraine, and addiction. Biotica Bio’s proprietary technology interacts with specific tissues and ameliorates inflammatory waves where they begin.

 
 
 

A convergence of biologies enables a first-in-class treatment

Biotica Bio’s products will reach the market 10x faster and 100x more affordably than traditional drugs and rely on established biology that is already at work within the human body.

 
 
LogoWave.png